Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia FHI Federated Hermes posts 153 Q4 2025 EPS beat while shares dip 108 in todays trading HCMAU HCM III delays release of full quarterly earnings details pending ongoing merger due diligence